Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome

References

• Urquhart DM, Wluka AE, van Tulder M, et al. Efficacy of Low-dose amitriptyline for chronic low back pain: a randomized clinical trial. JAMA Intern Med. 2018;178(11):1474–1481. doi:10.1001/jamainternmed.2018.422230285054
   PubMed Web of Science ®Google Scholar
• Jaaskelainen SK, Woda A. Burning mouth syndrome. Cephalalgia. 2017;37(7):627–647. doi:10.1177/033310241769488328569120
   PubMed Web of Science ®Google Scholar
• Suga T, Watanabe T, Aota Y, Nagamine T, Toyofuku A. Burning mouth syndrome: the challenge of an aging population. Geriatr Gerontol Int. 2018;18(12):1649–1650. doi:10.1111/ggi.2018.18.issue-1230548780
   PubMed Web of Science ®Google Scholar
• Hens MJ, Alonso-Ferreira V, Villaverde-Hueso A, Abaitua I, Posada de la Paz M. Cost-effectiveness analysis of burning mouth syndrome therapy. Community Dent Oral Epidemiol. 2012;40(2):185–192. doi:10.1111/j.1600-0528.2011.00645.x22044166
   PubMed Web of Science ®Google Scholar
• Breckons M, Shen J, Bunga J, Vale L, Durham J. DEEP study: indirect and out-of-pocket costs of persistent orofacial pain. J Dent Res. 2018;97:22034518773310.
   Web of Science ®Google Scholar
• Cooper TE, Heathcote LC, Clinch J, et al. Antidepressants for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev. 2017;8:CD012535.28779487
   PubMedGoogle Scholar
• Tu TTH, Takenoshita M, Matsuoka H, et al. Current management strategies for the pain of elderly patients with burning mouth syndrome: a critical review. Biopsychosoc Med. 2019;13:1. doi:10.1186/s13030-019-0142-730733824
   PubMed Web of Science ®Google Scholar
• Kojima T, Mizukami K, Tomita N, et al. Screening tool for older persons’ appropriate prescriptions for Japanese: report of the Japan Geriatrics Society Working Group on “Guidelines for medical treatment and its safety in the elderly”. Geriatr Gerontol Int. 2016;16(9):983–1001. doi:10.1111/ggi.1289027594406
   PubMed Web of Science ®Google Scholar
• Riediger C, Schuster T, Barlinn K, Maier S, Weitz J, Siepmann T. Adverse effects of antidepressants for chronic pain: a systematic review and meta-analysis. Front Neurol. 2017;8:307. doi:10.3389/fneur.2017.0030728769859
   PubMed Web of Science ®Google Scholar
• Fenelon M, Quinque E, Arrive E, Catros S, Fricain JC. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study. Int J Oral Maxillofac Surg. 2017. doi:10.1016/j.ijom.2017.03.032
   Web of Science ®Google Scholar
• Association AP. Practice guideline for the treatment of patients with major depressive disorder (3rd); 2009 Available from: http://psychiatryonlineorg/guidelines aspx
   Google Scholar
• Nishtala PS, McLachlan AJ, Bell JS, Chen TF. Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study. Am J Geriatr Pharmacother. 2009;7(4):210–219. doi:10.1016/j.amjopharm.2009.07.00119766953
   PubMedGoogle Scholar
• Katz P, Pegoraro V, Liedgens H. Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe - the role of the lidocaine 5% medicated plaster. Curr Med Res Opin. 2017;33(8):1481–1489. doi:10.1080/03007995.2017.133519128537441
   PubMed Web of Science ®Google Scholar
• Kato Y, Sato T, Katagiri A, et al. Milnacipran dose-effect study in patients with burning mouth syndrome. Clin Neuropharmacol. 2011;34(4):166–169. doi:10.1097/WNF.0b013e318227f10021738023
   PubMed Web of Science ®Google Scholar
• Takenoshita M, Sato T, Kato Y, et al. Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities. Neuropsychiatr Dis Treat. 2010;6:699–705. doi:10.2147/NDT.S1260521127687
   PubMed Web of Science ®Google Scholar
• Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30(2):191–197. doi:10.1016/0304-3959(87)91074-83670870
   PubMed Web of Science ®Google Scholar
• Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524–532. doi:10.1037/1040-3590.7.4.524
   Web of Science ®Google Scholar
• Gierk B, Kohlmann S, Kroenke K, et al. The somatic symptom scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Intern Med. 2014;174(3):399–407. doi:10.1001/jamainternmed.2013.1217924276929
   PubMed Web of Science ®Google Scholar
• Hurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther. 2004;27(1):26–35. doi:10.1016/j.jmpt.2003.11.00314739871
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5; Washington, DC: American Psychiatric Association; 2013.
   Google Scholar
• Ariyawardana A, Chmieliauskaite M, Farag AM, et al. World workshop on oral medicine VII: burning mouth syndrome: a systematic review of disease definitions and diagnostic criteria utilized in randomized clinical trials. Oral Dis. 2019. doi:10.1111/odi.13067
   Web of Science ®Google Scholar
• Rico-Villademoros F, Slim M, Calandre EP. Amitriptyline for the treatment of fibromyalgia: a comprehensive review. Expert Rev Neurother. 2015;15(10):1123–1150. doi:10.1586/14737175.2015.109172626395929
   PubMed Web of Science ®Google Scholar
• Lotrich FE, Pollock BG. Aging and clinical pharmacology: implications for antidepressants. J Clin Pharmacol. 2005;45(10):1106–1122. doi:10.1177/009127000528029716172176
   PubMed Web of Science ®Google Scholar
• Mori M, Koide T, Imanishi Y, Matsui Y, Matsuda T. Duloxetine-induced hyponatremia in an elderly patient treated with thiazide diuretics. Indian J Pharmacol. 2014;46(6):657–659. doi:10.4103/0253-7613.14494725538343
   PubMed Web of Science ®Google Scholar
• Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol. 2014;77(2):295–301. doi:10.1111/bcp.2014.77.issue-222882333
   PubMed Web of Science ®Google Scholar
• Goodman CW, Brett AS. Gabapentin and pregabalin for pain - is increased prescribing a cause for concern? N Engl J Med. 2017;377(5):411–414. doi:10.1056/NEJMp170463328767350
   PubMed Web of Science ®Google Scholar
• Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551. doi:10.1136/bmj.d455121810886
   PubMed Web of Science ®Google Scholar
• Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry. 2009;31(3):206–219. doi:10.1016/j.genhosppsych.2008.12.00619410099
   PubMed Web of Science ®Google Scholar
• Doyle Strauss L, Weizenbaum E, Loder EW, Rizzoli PB. Amitriptyline dose and treatment outcomes in specialty headache practice: a retrospective cohort study. Headache. 2016;56(10):1626–1634. doi:10.1111/head.2016.56.issue-1027775149
   PubMed Web of Science ®Google Scholar
• Rochester MP, Kane AM, Linnebur SA, Fixen DR. Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence. Ther Adv Drug Saf. 2018;9(6):297–308. doi:10.1177/204209861877297929854391
   PubMed Web of Science ®Google Scholar
• Tobias DE. Start low and go slow. Hosp Pharm. 2003;38(7):634–636. doi:10.1177/001857870303800707
   Google Scholar
• Rasu RS, Vouthy K, Crowl AN, et al. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States. J Managed Care Specialty Pharm. 2014;20(9):921–928. doi:10.18553/jmcp.2014.20.9.921
   PubMed Web of Science ®Google Scholar
• Moulin D, Boulanger A, Clark AJ, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag. 2014;19(6):328–335. doi:10.1155/2014/75469325479151
   PubMed Web of Science ®Google Scholar